Jove
Visualize
Contact Us

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same author

Changes in Cancer Stem Cell Signalling Pathways With Plant Metabolites to Discover Chemotherapy.

Chemistry & biodiversity·2026
Same author

Advancements in computational tools in proteomics: Revolutionizing data analysis.

International review of cell and molecular biology·2026
Same author

Copper-Redox Cycling by Flavonoid Alpinetin Leads to ROS-Mediated DNA Damage and Apoptosis: A Mechanism for Cancer Chemoprevention.

Current topics in medicinal chemistry·2026
Same author

Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein Stimulation.

Journal of proteome research·2026
Same author

Evaluating the efficacy of extracorporeal shockwave therapy in postoperative rehabilitation after anterior cruciate ligament reconstruction: A meta-analysis.

World journal of orthopedics·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 12, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Pathways to breast cancer recurrence.

Aamir Ahmad1

  • 1Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

ISRN Oncology
|March 28, 2013
PubMed
Summary

Breast cancer recurrence is a major challenge. This review explores cancer stem cells, EMT, signaling pathways, and miRNAs to understand and prevent recurrence.

Area of Science:

  • Oncology and Cancer Research
  • Molecular Biology
  • Cell Biology

Background:

  • Breast cancer recurrence remains a significant clinical challenge despite advancements in early detection and treatment.
  • A large number of patients experience fear and uncertainty due to the possibility of recurrent disease.
  • Understanding the mechanisms driving breast cancer recurrence is crucial for improving patient outcomes.

Purpose of the Study:

  • To provide a comprehensive overview of the current knowledge regarding breast cancer recurrence.
  • To examine the challenges associated with understanding and predicting disease recurrence.
  • To review emerging hypotheses and research areas focused on the prevention of breast cancer recurrence.

Main Methods:

  • Literature review and synthesis of existing research.

More Related Videos

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Related Experiment Videos

Last Updated: May 12, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

  • Exploration of key biological concepts including cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT).
  • Analysis of the roles of specific signaling pathways (Notch, Wnt, hedgehog) and microRNAs (miRNAs) in recurrence.
  • Main Results:

    • Identified CSCs and EMT as critical factors implicated in breast cancer recurrence.
    • Highlighted the involvement of Notch, Wnt, and hedgehog signaling pathways in the recurrence process.
    • Discussed the potential of miRNAs as regulators and biomarkers for breast cancer recurrence.

    Conclusions:

    • Breast cancer recurrence is a complex phenomenon influenced by CSCs, EMT, and specific signaling pathways.
    • Further research into these mechanisms is essential for developing effective strategies to prevent recurrence.
    • Investigating miRNAs offers a promising avenue for both understanding and targeting recurrent breast cancer.